About Us

Where High Tech Meets High Care.

For over forty years, we have been designing technologies that make processes in the radiopharmaceutical, pharmaceutical, and radiation therapy fields safer, supporting professionals, researchers, and industries in improving people’s lives through innovation, safety, precision, and care.

WHO WE ARE

Built on Care

Every day, in hospitals, research centers, and manufacturing facilities around the world, professionals are working to improve health and quality of life. Tema Sinergie develops technologies, systems, and services that help them do so more safely, accurately, and efficiently.
Founded in Faenza in 1985, the company has grown to

To become an international partner in the fields of nuclear medicine, radiopharmacy, cancer radiation therapy, and the pharmaceutical industry. We work by integrating engineering, multidisciplinary expertise, and ongoing collaboration with clients and partners, transforming complex needs into concrete solutions.

Making Better

We believe that technology has value only when it improves people’s lives.

That’s why every project starts with a simple principle: putting High Care at the center. Care means responsibility, listening, quality, and attention to those who use our technologies and to the patients who indirectly benefit from them.

High Tech, High Care isn’t just a tagline—it’s how we design, collaborate, and innovate every day.

HOW WE WORK

Designed Around People

Turning ideas into reliable solutions requires much more than just technical expertise. It requires listening, collaboration, and a deep understanding of the needs of those working in highly regulated and critical environments.

We work side by side with customers, scientific partners, and institutions to develop technologies that address real-world needs. From design to installation, from validation to after-sales support, we guide every project with an approach focused on long-term partnerships.

Liability

toward people, patients, and communities

Continuous Innovation

to prepare for the challenges of the future

Your Excellency

in quality and execution

Collaboration

as a driver of shared growth

Integrity

in relationships and decisions

Where We Make a Difference

The challenges in healthcare and the life sciences are increasingly interconnected. That is why we operate as a single ecosystem of expertise that supports the entire patient journey: from research to manufacturing, from diagnosis to treatment.

Radiopharma Production & Nuclear Medicine

We support the safe production, handling, and administration of radiopharmaceuticals, contributing to the development of personalized medicine and theranostics.

Pharma & Biotech

We design advanced containment systems and integrated solutions for pharmaceutical processes and innovative therapies, helping companies ensure quality, safety, and compliance.

Radiation Oncology & Medical Imaging

We provide technologies and expertise that support accurate diagnoses and increasingly effective cancer treatments, helping to improve the experience for both healthcare professionals and patients.

Always Moving Forward

Innovation isn't a department. It's a way of working.

Topic: corporate_computer_executive_synergies - copy 3

“

Every new technology arises from the convergence of engineering expertise, hands-on experience, and ongoing dialogue with the international scientific community.

We constantly invest in research and development to transform new ideas into practical applications, collaborating with hospitals, universities, research centers, and industry partners. This approach allows us to anticipate market changes and contribute to the evolution of clinical and manufacturing practices.

— Stefano Piancastelli | CEO

The People Behind the Technology

Behind every technology are people who share expertise, responsibility, and a common vision.

At Tema Sinergie, we believe that innovation is the result of collaboration among different professionals: engineers, technicians, project managers, product specialists, production staff, and support functions work together every day as a single team.

We invest in the continuous growth of our people by promoting training, knowledge sharing, and professional development. We foster a work environment where curiosity, initiative, and collaboration are the key elements that enable us to successfully tackle the challenges of a constantly evolving industry.

For us, people aren’t just part of the company—they are the driving force behind our ability to innovate.

Join Tema Sinergie

Data That Demonstrate Reliability

2,400+

customers worldwide

400+ people

Multidisciplinary team

90+ countries

featuring installations

20,500 m²

headquarters

5 companies

part of the Tema Sinergie group

Topic: corporate_computer_executive_synergies - copy 5

Our History

For over 40 years, we have been driving innovation, setting industry standards, and solidifying our position as a global leader.

1985

Tema Sinergie was founded to supply shielded accessories and
manipulation tools for nuclear power plants. After the 1986 Chernobyl
disaster, the Italian market declined, prompting the company to shift its focus to the medical sector.

1990

By supporting research institutes and the first Nuclear Medicine
Departments in Italy, Tema Sinergie began designing, manufacturing,
and installing radioactive organic waste systems, shielded doors, radiation monitors, and calibration irradiators.

1993

Active in radiotherapy with shielded doors and radiation monitoring systems, Tema Sinergie gained Italian distribution rights for international radiotherapy brands, launching a new business: equipment resale for Radiotherapy and Medical Physics
Departments.

2005

The global development of PET (Positron Emission Tomography) is opening new doors, and Tema Sinergie has entered this market by launching its first automatic dispenser. The Company is committed to innovation and process automation.

2012

Recognized globally as a leader in shielded isolators, Tema Sinergie expanded its portfolio by designing
and manufacturing barrier systems, isolators, and integrated solutions for the Pharma & Biotech sectors.

2022

The Company is quickly growing up; the introduction of Theranostics is
significantly expanding the target market.
A new business partner, Charme Capital Partners private equity fund, has joined Tema Sinergie, holding 70% of the shares.

2023

The Company establishes its very first branch office in the USA. The office is focused on after-sales service, enabling our technicians to operate more efficiently within the North American territory.

2024

As the Company’s expansion accelerates, the facility triples in size,
reaching 20,500 m2. Our team continues to grow steadily, reflecting
strong momentum. Strategic acquisitions were completed to further strengthen production capabilities and support long-term growth.

2025

Tema Sinergie acquired the Spanish company 6BIO, a key player in the filling sector, strengthening its expertise and expanding capabilities across both Pharma and Radiopharma markets.